基于人群的组织性粪便免疫化学检测筛查与结直肠癌死亡率:一项自然实验
该研究利用西班牙50个省份1999–2016年的准实验设计,评估2010年前11个省份开展50–69岁平均风险人群FIT组织性筛查对结直肠癌死亡率与发病率的人群影响。结果显示筛查实施2年后年龄标化发病率平均增加10.08%,7年后年龄标化死亡率降低8.82%,男女结果相似,未筛查年龄组及10种其他主要死因未见关联变化。
要点
- FIT组织性筛查实施2年后结直肠癌年龄标化发病率平均增加10.08%。
- 筛查实施7年后结直肠癌年龄标化死亡率降低8.82%,男女相似。
- 未筛查年龄组及10种其他主要死因未见关联变化。
核心结论
- 西班牙基于FIT的组织性筛查与人群结直肠癌死亡率下降相关。
研究设计与样本
- 准实验设计,覆盖西班牙50个省份1999–2016年数据。
- 2010年前11个省份开展50–69岁平均风险人群FIT组织性筛查,36个省份为对照。
- 采用双重差分法和合成控制分析评估筛查相关结局变化动态。
主要发现
- 筛查实施前7年内暴露省与对照省结局趋势无差异。
- 筛查实施2年后暴露省年龄标化发病率平均增加10.08%[95%CI(5.09,15.07)]。
- 筛查实施7年后结直肠癌年龄标化死亡率降低8.82%[95%CI(3.77,13.86)]。
- 女性和男性结果相似。
- 未筛查年龄组及10种其他主要死因未见关联变化。
临床怎么用
- 支持在平均风险人群中推行基于FIT的组织性结直肠癌筛查以降低人群死亡率。
- 筛查早期发病率上升可能与检出增加有关,需结合死亡率长期随访评估效果。
局限性
- 作者指出需进一步研究评估结果的 replicability 与外部有效性。
- 作者指出需进一步研究组织性筛查中FIT的性别特异性使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Population-based organized screening programmes for colorectal cancer (CRC) are underway worldwide, with many based on the faecal immunochemical test (FIT). No clinical trials assessing FIT compared with no screening are planned, and few studies have assessed the population impact of such programmes. METHODS: Before 2010, 11 out of 50 Spanish provinces initiated population-based organized screening programmes with FIT for an average-risk population aged 50-69 years. We used a quasi-experimental design across Spanish provinces between 1999 and 2016 to evaluate their impact on population age-standardized mortality and incidence rates due to CRC. Difference-in-differences and synthetic control analyses were performed to test for validation of statistical assumptions and to assess the dynamics of screening-associated changes in outcomes over time. RESULTS: No differences in outcome trends between exposed (n = 11) and control (n = 36) provinces were observed for up to 7 years preceding the implementation of screening. Relative to controls, exposed provinces experienced a mean increase in age-standardized incidence of 10.08% [95% confidence interval (CI) (5.09, 15.07)] 2 years after implementation, followed by a reduction in age-standardized mortality rates due to CRC of 8.82% [95% CI (3.77, 13.86)] after 7 years. Results were similar for both women and men. No associated changes were observed in adjacent age bands not targeted by screening, nor for 10 other major causes of death in the exposed provinces. CONCLUSIONS: FIT-based organized screening in Spain was associated with reductions in population colorectal cancer mortality. Further research is warranted in order to assess the replicability and external validity of our findings, and on gender-specific use of FIT in organized screening.
引用
- Keys MT, Serra-Burriel M, Martínez-Lizaga N, et al. Population-based organized screening by faecal immunochemical testing and colorectal cancer mortality: a natural experiment. Int J Epidemiol. 2021. PMID: 33211822. doi:10.1093/ije/dyaa166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。